DEBORAH PACHECO: Open Payments
NPI 1790167641 · LAS CRUCES, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,443 in 60 payments from 19 companies in 2025. Trend: 2023 $633 · 2024 $1,442 · 2025 $1,443
Food & beverage: $1,438Education: $5
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $401 |
| ABBVIE INC. | 13 | $185 |
| Viatris Specialty LLC | 7 | $158 |
| Insulet Corporation | 2 | $121 |
| Medtronic, Inc. | 1 | $119 |
| Lilly USA, LLC | 4 | $74 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| Axsome Therapeutics, Inc. | 3 | $61 |
| Lundbeck LLC | 2 | $59 |
| Xeris Pharmaceuticals, Inc. | 2 | $42 |
Products named: FARXIGA, YUPELRI, OMNIPOD, SYMPLICITY G3, VRAYLAR, AIRSUPRA, BREZTRI, Kerendia.
Industry payments across NM — which companies pay providers there.
